Sentinel Trust CO Lba Biogen Inc. Transaction History

Sentinel Trust CO Lba

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $1.48 Million - $2.32 Million	-6,830 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$278.5 - $352.75 $155,960 - $197,540	560 Added 8.93%	6,830 $2.06 Million
Q3 2018 Nov 15, 2018	SELL	$293.51 - $383.83 $2.03 Million - $2.66 Million	-6,920 Reduced 52.46%	6,270 $0
Q2 2018 Aug 15, 2018	SELL	$257.52 - $306.91 $829,214 - $988,250	-3,220 Reduced 19.62%	13,190 $0
Q1 2018 May 16, 2018	BUY	$260.13 - $367.91 $137,868 - $194,992	530 Added 3.34%	16,410 $0
Q4 2017 Feb 15, 2018	BUY	$307.64 - $344.58 $3.04 Million - $3.41 Million	9,895 Added 165.33%	15,880 $0
Q3 2017 Oct 12, 2017	BUY	$281.15 - $329.69 $1.68 Million - $1.97 Million	5,985	5,985 $0

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Sentinel Trust CO Lba, based on Form 13F filings with the SEC.

Stay updated on Sentinel Trust CO Lba with notifications on news.